<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05617898</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300009711</org_study_id>
    <nct_id>NCT05617898</nct_id>
  </id_info>
  <brief_title>Determining the Role of Social Reward Learning in Social Anhedonia</brief_title>
  <acronym>SAMI</acronym>
  <official_title>Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis Using Motivational Interviewing in a Perturbation-Based Neuroimaging Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a clinical trial study that aims to evaluate the specificity of the relationship&#xD;
      between reduced sensitivity to social reward and social anhedonia at both behavioral and&#xD;
      neural levels. Individuals who recently experienced their first-episode psychosis will be&#xD;
      recruited. Participants will be randomized 1:1 to motivational interviewing or a time- and&#xD;
      format-matched control probe. At pre- and post-probe, participants will perform two social&#xD;
      reward learning tasks in the scanner. With this design feature, we will examine the&#xD;
      relationship between sensitivity to social reward and reduced subjective experience of social&#xD;
      pleasure at both the behavioral and neural levels.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2023</start_date>
  <completion_date type="Anticipated">November 2027</completion_date>
  <primary_completion_date type="Anticipated">November 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response Bias</measure>
    <time_frame>3 weeks</time_frame>
    <description>Response bias is defined as the likelihood of making one response, such as the frequently rewarded stimulus, more than the other response during the perceptual social reward learning task</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the number of optimal response</measure>
    <time_frame>3 weeks</time_frame>
    <description>The number of optimal response is defined as the number of responses choosing a stimuli with optimal outcomes (e.g., choosing a good over a neutral machine or choosing a neutral over a bad machine) during the inductive social reward learning task.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fMRI activation levels</measure>
    <time_frame>3 weeks</time_frame>
    <description>fMRI activation is defined as beta weights from general linear model from key regions of interests including the ventromedial prefrontal cortex, dorsal anterior cingulate cortex and ventral striatum during the perceptual social reward learning task and the inductive social reward learning task.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Psychosis</condition>
  <arm_group>
    <arm_group_label>Motivational Interview Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm involves three 45-minute sessions on motivational interviewing targeting sensitivity to social reward.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Control Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm involves three 45-minute sessions on didactic training on nutrition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Interviewing</intervention_name>
    <description>Three motivational interviewing sessions will target sensitivity to social reward, including subjective evaluation of social interaction, socially rewarding stimuli, and events (e.g., interactions with others, feedback from others).</description>
    <arm_group_label>Motivational Interview Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Nutrition Didactic Training</intervention_name>
    <description>The Nutrition didactic training will ask participants to discuss pros and cons of healthy eating habits and how to improve their current eating habits.</description>
    <arm_group_label>Active Control Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-35 years&#xD;
&#xD;
          -  A first episode of a psychotic illness that began within the past two years&#xD;
&#xD;
          -  Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of&#xD;
             schizophrenia, schizophreniform, or schizoaffective disorder (depressed type)&#xD;
&#xD;
          -  Taking 2nd generation antipsychotic medications&#xD;
&#xD;
          -  Estimated premorbid IQ not less than 70 as assessed with the Wechsler Test of Adult&#xD;
             Reading&#xD;
&#xD;
          -  Appropriate for scanning (i.e., no pacemaker or metal implants) and expressed&#xD;
             willingness to participate in scanning&#xD;
&#xD;
          -  Sufficient fluency in English to comprehend testing procedures&#xD;
&#xD;
          -  Corrected vision of at least 20/30&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No evidence that substance use makes the diagnosis ambiguous (rule out&#xD;
             substance-induced psychosis)&#xD;
&#xD;
          -  No evidence of moderate or severe alcohol or substance use disorder in the past 3&#xD;
             months&#xD;
&#xD;
          -  No clinically significant disease based on medical history (e.g., epilepsy) or&#xD;
             significant head injury&#xD;
&#xD;
          -  For females: no current pregnancy&#xD;
&#xD;
          -  No sedatives or anxiolytics on the day of assessment&#xD;
&#xD;
          -  No medication change 3 weeks prior to enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Junghee Lee, PhD</last_name>
    <phone>205-934-8205</phone>
    <email>jungheelee@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrew Meddaugh, BA</last_name>
    <phone>205-934-8203</phone>
    <email>ajmeddaugh@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrew Meddaugh, BA</last_name>
      <phone>205-934-8203</phone>
      <email>ajmeddaugh@uabmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Junghee Lee, PhD</last_name>
      <phone>205-934-8205</phone>
      <email>jungheelee@uabmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Junghee Lee, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrienne C Lahti, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alison Thomas, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caitlin W Clevenger, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gerhard S Hellemann, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Rebecca Zornitsky, MS</last_name>
      <phone>424-225-1779</phone>
      <email>zornitsky@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Joseph Ventura, PhD</last_name>
      <phone>310-206-3142</phone>
      <email>jventura@mednet.ucla.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Keith H Nuechterlein, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael F Green, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Ventura, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Subotnik, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amy M Jimenez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lena M Reddy, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2023</verification_date>
  <study_first_submitted>October 31, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>May 1, 2023</last_update_submitted>
  <last_update_submitted_qc>May 1, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Junghee Lee</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>social anhedonia, social reward learning, fMRI, sensitivity to reward</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anhedonia</mesh_term>
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

